We are live on ! Find out more
CA

Calton & Associates Portfolio holdings

AUM $683M
1-Year Est. Return 28.95%
This Fund
S&P 500
This Quarter Est. Return
+12.46%
1 Year Est. Return
+28.95%
3 Year Est. Return
+73.86%
5 Year Est. Return
+79.5%
10 Year Est. Return
AUM
$560M
AUM Growth
+$73.4M
Cap. Flow
+$17.4M
Cap. Flow %
3.11%
Top 10 Hldgs %
35.89%
Holding
404
New
56
Increased
149
Reduced
167
Closed
22

Sector Composition

Rank Sector Weight
1 Technology 6.95%
2 Healthcare 3.72%
3 Financials 2.67%
4 Consumer Discretionary 2.34%
5 Communication Services 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTSL icon
226
First Trust Senior Loan Fund ETF
FTSL
$2.33B
$358K 0.06%
7,525
+13
+0.2% +$607
EWC icon
227
iShares MSCI Canada ETF
EWC
$6.48B
$356K 0.06%
11,540
-161
-1% -$4.72K
PM icon
228
Philip Morris
PM
$290B
$353K 0.06%
4,259
+48
+1% +$3.74K
NSC icon
229
Norfolk Southern
NSC
$75.2B
$352K 0.06%
1,479
-690
-32% -$157K
XME icon
230
State Street SPDR S&P Metals & Mining ETF
XME
$4.56B
$346K 0.06%
10,346
-691
-6% -$19.6K
VBR icon
231
Vanguard Morningstar Small-Cap Value ETF
VBR
$38B
$345K 0.06%
2,425
+354
+17% +$45.7K
CAT icon
232
Caterpillar
CAT
$388B
$341K 0.06%
1,874
-391
-17% -$66.3K
MRNA icon
233
Moderna
MRNA
$24.2B
$340K 0.06%
3,258
+243
+8% +$24.6K
EWZ icon
234
iShares MSCI Brazil ETF
EWZ
$8.6B
$339K 0.06%
9,150
-65
-0.7% -$2.1K
RMD icon
235
ResMed
RMD
$32.6B
$339K 0.06%
1,595
+2
+0.1% +$399
RTX icon
236
RTX Corp
RTX
$302B
$338K 0.06%
4,730
+148
+3% +$9.73K
GSK icon
237
GSK
GSK
$102B
$337K 0.06%
7,318
-1,101
-13% -$50.6K
ETR icon
238
Entergy
ETR
$49.7B
$336K 0.06%
6,730
+190
+3% +$10K
MAIN icon
239
Main Street Capital
MAIN
$5.52B
$334K 0.06%
10,340
-1,549
-13% -$47.6K
SPTL icon
240
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.7B
$334K 0.06%
7,397
+773
+12% +$35.1K
RSP icon
241
Invesco S&P 500 Equal Weight ETF
RSP
$99.4B
$333K 0.06%
+2,614
New +$311K
SDY icon
242
State Street SPDR S&P Dividend ETF
SDY
$22.1B
$333K 0.06%
3,142
-692
-18% -$70K
LVS icon
243
Las Vegas Sands
LVS
$29.6B
$332K 0.06%
5,575
-5,300
-49% -$283K
ACN icon
244
Accenture
ACN
$110B
$328K 0.06%
1,254
+16
+1% +$3.83K
SO icon
245
Southern Company
SO
$106B
$326K 0.06%
5,312
-2,426
-31% -$146K
MDLZ icon
246
Mondelez International
MDLZ
$78.9B
$325K 0.06%
5,551
+109
+2% +$6.23K
AWK icon
247
American Water Works
AWK
$27B
$323K 0.06%
2,105
-59
-3% -$9.08K
GTO icon
248
Invesco Total Return Bond ETF
GTO
$2.47B
$322K 0.06%
+5,582
New +$324K
QUAL icon
249
iShares MSCI USA Quality Factor ETF
QUAL
$48B
$321K 0.06%
+2,764
New +$304K
ZLAB icon
250
Zai Lab
ZLAB
$2.92B
$320K 0.06%
2,361
-84
-3% -$8.55K

Similar funds

Calton & Associates's Q4 2020 Portfolio in Review

As of Q4 2020, Calton & Associates held 404 positions worth $560M, up 15% from $487M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Calton & Associates deployed $17.4M of net new capital in Q4 2020, opening 56 new positions and adding to 149 existing holdings. Its largest new stake was iShares S&P Small-Cap 600 Value ETF: 57,832 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Russell 1000 Growth ETF, an estimated $9.83M trimmed.

  • Calton & Associates's largest Q4 2020 buy was iShares S&P Small-Cap 600 Value ETF: 57,832 shares worth $4.7M.
  • Calton & Associates added most to iShares Core S&P Total US Stock Market ETF in Q4 2020, an estimated $11M increase.
  • Calton & Associates's biggest Q4 2020 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $9.83M.
  • Calton & Associates fully exited Immunomedics Inc in Q4 2020, selling an estimated $3.79M.
  • Calton & Associates's ten largest holdings make up 36% of its $560M portfolio in Q4 2020.
  • Calton & Associates opened 56 new positions and closed 22 in Q4 2020.
  • Calton & Associates's portfolio value rose 15% quarter-over-quarter to $560M.

Based on Calton & Associates's 13F filing for Q4 2020, filed 25 Jan 2021.